| ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways T Kuriakose, SM Man, RK Subbarao Malireddi, R Karki, S Kesavardhana, ... Science immunology 1 (2), aag2045-aag2045, 2016 | 660 | 2016 |
| Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis) S Christgen, M Zheng, S Kesavardhana, R Karki, RKS Malireddi, ... Frontiers in cellular and infection microbiology 10, 237, 2020 | 369 | 2020 |
| DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome P Samir, S Kesavardhana, DM Patmore, S Gingras, RKS Malireddi, ... Nature 573 (7775), 590-594, 2019 | 362 | 2019 |
| Recent advances in inflammasome biology DE Place, TD Kanneganti Current opinion in immunology 50, 32-38, 2018 | 340 | 2018 |
| IRGB10 liberates bacterial ligands for sensing by the AIM2 and caspase-11-NLRP3 inflammasomes SM Man, R Karki, M Sasai, DE Place, S Kesavardhana, J Temirov, ... Cell 167 (2), 382-396. e17, 2016 | 306 | 2016 |
| Toward targeting inflammasomes: insights into their regulation and activation S Christgen, DE Place, TD Kanneganti Cell research 30 (4), 315-327, 2020 | 244 | 2020 |
| PANoptosis in microbial infection DE Place, SJ Lee, TD Kanneganti Current opinion in microbiology 59, 42-49, 2021 | 180 | 2021 |
| DNA sensing in the innate immune response B Briard, DE Place, TD Kanneganti Physiology, 2020 | 178 | 2020 |
| IRF8 regulates transcription of Naips for NLRC4 inflammasome activation R Karki, D Place, P Samir, J Mavuluri, BR Sharma, A Balakrishnan, ... Cell 173 (4), 920-933. e13, 2018 | 176 | 2018 |
| Interferon-inducible guanylate-binding proteins at the interface of cell-autonomous immunity and inflammasome activation SM Man, DE Place, T Kuriakose, TD Kanneganti Journal of Leucocyte Biology 101 (1), 143-150, 2017 | 121 | 2017 |
| Galactosaminogalactan activates the inflammasome to provide host protection B Briard, T Fontaine, P Samir, DE Place, L Muszkieta, RKS Malireddi, ... Nature 588 (7839), 688-692, 2020 | 108 | 2020 |
| Cell death–mediated cytokine release and its therapeutic implications DE Place, TD Kanneganti Journal of Experimental Medicine 216 (7), 1474-1486, 2019 | 82 | 2019 |
| Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins DE Place, RKS Malireddi, J Kim, P Vogel, M Yamamoto, TD Kanneganti Nature Communications 12 (1), 496, 2021 | 77 | 2021 |
| Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection B Briard, R Karki, RKS Malireddi, A Bhattacharya, DE Place, J Mavuluri, ... Nature microbiology 4 (2), 316-327, 2019 | 72 | 2019 |
| The innate immune system and cell death in autoinflammatory and autoimmune disease DE Place, TD Kanneganti Current opinion in immunology 67, 95-105, 2020 | 66 | 2020 |
| DDX3X coordinates host defense against influenza virus by activating the NLRP3 inflammasome and type I interferon response S Kesavardhana, P Samir, M Zheng, RKS Malireddi, R Karki, BR Sharma, ... Journal of Biological Chemistry 296, 2021 | 45 | 2021 |
| A dominant negative Cx43 mutant differentially affects tumorigenic and invasive properties in human metastatic melanoma cells SN Zucker, TA Bancroft, DE Place, B Des Soye, A Bagati, R Berezney Journal of cellular physiology 228 (4), 853-859, 2013 | 32 | 2013 |
| Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection-or vaccination-induced immunity against Bordetella pertussis X Zhang, SE Hester, MJ Kennett, AT Karanikas, L Bendor, DE Place, ... Infection and immunity 79 (1), 527-541, 2011 | 25 | 2011 |
| First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers F Tang, R Kunder, T Chu, A Hains, A Nguyen, JM McBride, Y Zhong, ... Clinical and Translational Science 16 (9), 1653-1666, 2023 | 24 | 2023 |
| ASK family kinases are required for optimal NLRP3 inflammasome priming DE Place, P Samir, R Karki, B Briard, P Vogel, TD Kanneganti The American Journal of Pathology 188 (4), 1021-1030, 2018 | 24 | 2018 |
Thirumala-Devi KannegantiSt. Jude Children's Research HospitalΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα stjude.org
